Skip to content

Physician Radiation Exposure During Radial Access Cardiac Catheterization Using a RAD Board

Reduction in Physician Radiation Exposure During Radial Access Cardiac Catheterization Using a Radiation Protection Board

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02088788
Enrollment
265
Registered
2014-03-17
Start date
2013-06-30
Completion date
2014-10-31
Last updated
2018-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation Exposure to Operator

Keywords

radiation, radiation injury, occupational risk

Brief summary

Radiation exposure to operator is an occupational hazard of invasive cardiologists. During radial access for diagnostic catheterization, a new radio-dense arm board is advertised to reduce operator radiation exposure. The investigators randomize patients to a new radio-dense armboard versus a standard radio-transparent armboard during diagnostic catheterization and measure radiation exposure to the operator. Both groups have a radio-dense pelvic shield in place. The investigators hypothesize that operator radiation dose will be decreased by use of the radio-dense armboard.

Detailed description

Hypothesis: Compared to standard shielding with a lead pelvic drape alone, using a radio-opaque arm board in addition to the pelvic drape will decrease operator radiation exposure during radial access cardiac catheterization by at least 30%. STUDY DESIGN This is a randomized, prospective study where patients will be randomized by random numbers in sealed envelopes to standard shielding (pelvic drape alone, the no-board group) or to experimental shielding (pelvic drape plus radiation board, the board group). A robust radiation safety monitoring program is in place. Patient exposure is measured by the catheterization laboratory equipment and recorded. Lindauer Microstar Nanodot badges worn at waist level above the radiation lead will be used to measure operator radiation exposure. A new Nanodot will be used for every case. Radiation exposure to the operator's Nanodot will be measured immediately after each procedure by a technician blinded to study assignment. All patients 18-89 years old presenting to Geisinger Medical Center for diagnostic cardiac catheterization will be evaluated for the study. All interventional or diagnostic cardiologists and fellows that will be performing the cardiac catheterization procedure also will be study subjects. Approximately 215 Geisinger patients who satisfy inclusion and exclusion criteria will be included. Approximately 6 interventional cardiologists, 2 diagnostic cardiologists and 10 fellows will be included in this study.

Interventions

DEVICEBoard

Also has radio-dense pelvic shielding

DEVICENo Board

Radio-lucent armboard for radial access with radio-dense drape across pelvis

Sponsors

Geisinger Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

Operators: Interventional or diagnostic interventional attendings and fellows, operators willing to participate. Patients: Age 18-89 years old requiring catheterization at Geisinger Medical Center using radial access

Exclusion criteria

* patients with CABG, requiring extensive imaging, with operator switch during the procedure * patients in whom the procedure took unusual time because of anatomic issues, and need to switch to alternative access.

Design outcomes

Primary

MeasureTime frameDescription
Operator Radiation Exposureduring initial diagnostic catheterization procedure, an average of 30 minutesmSieverts radiation dose to the operator during diagnostic catheterization

Secondary

MeasureTime frameDescription
Radiation Exposure to Operator During Diagnostic Catheterization With Versus Without Ventriculography/AortographyDuring procedure, an average of 35 minutesmSieverts radiation dose to the operator during diagnostic catheterization with versus without ventriculography/aortography. This outcome measure includes 2 types of procedures: diagnostic catheterization plus LV gram and diagnostic catheterization plus aortography. Ventriculography is defined as injection through a pigtail catheter into the left ventricle using a power injector. Aortography is defined as injection through a pigtail catheter into the aorta using a power injector.

Countries

United States

Participant flow

Participants by arm

ArmCount
Board (Rad Board)
Radial artery catheterization is performed using radio-opaque armboard Board: Also has radio-dense pelvic shielding
105
No Board
Regular radio-penetrating armboard is used (the one normally used during non-study procedures) with a radio-opaque pelvic shield No Board: Radio-lucent armboard for radial access with radio-dense drape across pelvis
89
Total194

Baseline characteristics

CharacteristicBoard (Rad Board)No BoardTotal
Age, Continuous64.8 years
STANDARD_DEVIATION 12.1
64.2 years
STANDARD_DEVIATION 9.5
64.5 years
STANDARD_DEVIATION 10.94
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
37 Participants38 Participants75 Participants
Sex: Female, Male
Male
68 Participants51 Participants119 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Operator Radiation Exposure

mSieverts radiation dose to the operator during diagnostic catheterization

Time frame: during initial diagnostic catheterization procedure, an average of 30 minutes

ArmMeasureValue (MEDIAN)
Board (Rad Board)Operator Radiation Exposure.65 mSv
No BoardOperator Radiation Exposure.56 mSv
Secondary

Radiation Exposure to Operator During Diagnostic Catheterization With Versus Without Ventriculography/Aortography

mSieverts radiation dose to the operator during diagnostic catheterization with versus without ventriculography/aortography. This outcome measure includes 2 types of procedures: diagnostic catheterization plus LV gram and diagnostic catheterization plus aortography. Ventriculography is defined as injection through a pigtail catheter into the left ventricle using a power injector. Aortography is defined as injection through a pigtail catheter into the aorta using a power injector.

Time frame: During procedure, an average of 35 minutes

ArmMeasureGroupValue (MEDIAN)
Board (Rad Board)Radiation Exposure to Operator During Diagnostic Catheterization With Versus Without Ventriculography/AortographyWith Ventriculogram/aortogram.65 mSv
Board (Rad Board)Radiation Exposure to Operator During Diagnostic Catheterization With Versus Without Ventriculography/AortographyWithout ventriculogram/aortogram.66 mSv
No BoardRadiation Exposure to Operator During Diagnostic Catheterization With Versus Without Ventriculography/AortographyWith Ventriculogram/aortogram.61 mSv
No BoardRadiation Exposure to Operator During Diagnostic Catheterization With Versus Without Ventriculography/AortographyWithout ventriculogram/aortogram.54 mSv

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026